We are live on
!
Find out more
TAF
Tredje AP-fonden Portfolio holdings
AUM
$22.1B
1-Year Est. Return
41.68%
This Fund
S&P 500
This Quarter
Est. Return
+13%
1 Year Est. Return
+41.68%
3 Year Est. Return
+127.87%
5 Year Est. Return
+164.02%
10 Year Est. Return
+659.26%
AUM
$8.01B
AUM Growth
+$1.23B
(+18%)
Cap. Flow
+$393M
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
32.59%
Holding
557
New
21
Increased
181
Reduced
226
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$56.2M |
| 2 |
Morgan Stanley
MS
|
+$45.4M |
| 3 |
NVIDIA
NVDA
|
+$38.2M |
| 4 |
Amazon
AMZN
|
+$37.1M |
| 5 |
Microsoft
MSFT
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$35.8M |
| 2 |
Johnson & Johnson
JNJ
|
+$24.2M |
| 3 |
K
Kellanova
K
|
+$21.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$20.1M |
| 5 |
United Rentals
URI
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.64% |
| 2 | Healthcare | 14.83% |
| 3 | Financials | 12.74% |
| 4 | Consumer Discretionary | 11.83% |
| 5 | Communication Services | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
West Pharmaceutical
WST
$24.6B
| $4.12M | 0.05% |
11,694
-3,826
| -25% | -$1.35M |
|
227
HDFC Bank
HDB
$119B
| $4.09M | 0.05% |
122,000
| – | – |
|
|
228
Regeneron Pharmaceuticals
REGN
$81.9B
| $4.07M | 0.05% |
4,638
-43,469
| -90% | -$35.8M |
|
229
Cummins
CMI
$87.9B
| $4.02M | 0.05% |
16,760
+1,010
| +6% | +$230K |
|
230
Host Hotels & Resorts
HST
$15.5B
| $4M | 0.05% |
205,287
-2,477
| -1% | -$42.5K |
|
231
Goldman Sachs
GS
$305B
| $3.98M | 0.05% |
10,323
-4,670
| -31% | -$1.56M |
|
232
Quanta Services
PWR
$103B
| $3.95M | 0.05% |
18,302
-1,458
| -7% | -$269K |
|
233
Cardinal Health
CAH
$55.1B
| $3.93M | 0.05% |
39,004
-27,640
| -41% | -$2.74M |
|
|
SPLK
234
DELISTED
Splunk Inc
SPLK
| $3.9M | 0.05% |
25,610
-353
| -1% | -$52.7K |
|
235
State Street
STT
$52.1B
| $3.86M | 0.05% |
+49,883
| New | +$3.48M |
|
236
lululemon athletica
LULU
$14B
| $3.86M | 0.05% |
7,554
| – | – |
|
237
Broadridge
BR
$19.1B
| $3.85M | 0.05% |
18,701
-772
| -4% | -$142K |
|
238
Ecolab
ECL
$78.7B
| $3.85M | 0.05% |
19,397
| – | – |
|
239
Alnylam Pharmaceuticals
ALNY
$29.9B
| $3.79M | 0.05% |
19,791
-765
| -4% | -$130K |
|
240
T. Rowe Price
TROW
$23.8B
| $3.78M | 0.05% |
+35,108
| New | +$3.5M |
|
241
Ulta Beauty
ULTA
$23B
| $3.77M | 0.05% |
7,699
-518
| -6% | -$219K |
|
242
Sysco
SYY
$40.1B
| $3.74M | 0.05% |
51,197
+4,200
| +9% | +$290K |
|
243
Aptiv
APTV
$10.3B
| $3.74M | 0.05% |
41,678
+17,590
| +73% | +$1.51M |
|
244
FedEx
FDX
$76.4B
| $3.72M | 0.05% |
14,690
+2,400
| +20% | +$610K |
|
245
Cloudflare
NET
$112B
| $3.71M | 0.05% |
44,539
-2,097
| -4% | -$147K |
|
246
Church & Dwight Co
CHD
$24.1B
| $3.68M | 0.05% |
38,956
-1,360
| -3% | -$124K |
|
247
Align Technology
ALGN
$12.2B
| $3.66M | 0.05% |
13,363
-6,795
| -34% | -$1.61M |
|
248
HCA Healthcare
HCA
$88.8B
| $3.64M | 0.05% |
13,450
+2,190
| +19% | +$541K |
|
249
M&T Bank
MTB
$36.5B
| $3.6M | 0.05% |
26,274
-19,611
| -43% | -$2.46M |
|
250
Eastman Chemical
EMN
$8.38B
| $3.54M | 0.04% |
39,425
-1,861
| -5% | -$148K |
|
Similar funds
BA
FAM
MMH
CAM
CHP
VARA
Tredje AP-fonden's Q4 2023 Portfolio in Review
As of Q4 2023, Tredje AP-fonden held 557 positions worth $8.01B, up 18% from $6.78B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Tredje AP-fonden deployed $393M of net new capital in Q4 2023, opening 21 new positions and adding to 181 existing holdings. Its largest new stake was Capital One: 190,000 shares worth $24.9M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $35.8M trimmed.
- Tredje AP-fonden's largest Q4 2023 buy was Capital One: 190,000 shares worth $24.9M.
- Tredje AP-fonden added most to Microchip Technology in Q4 2023, an estimated $56.2M increase.
- Tredje AP-fonden's biggest Q4 2023 reduction was Regeneron Pharmaceuticals, cutting an estimated $35.8M.
- Tredje AP-fonden fully exited Activision Blizzard in Q4 2023, selling an estimated $13.6M.
- Tredje AP-fonden's ten largest holdings make up 33% of its $8.01B portfolio in Q4 2023.
- Tredje AP-fonden opened 21 new positions and closed 40 in Q4 2023.
- Tredje AP-fonden's portfolio value rose 18% quarter-over-quarter to $8.01B.
Based on Tredje AP-fonden's 13F filing for Q4 2023, filed 12 Feb 2024.